| Date | Company Name | Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|---|
| Oct 11, 2022 | Treeline Biosciences | Series A | — | Biotechnology | — |
| Jul 18, 2022 | Immunocore | Post-IPO Equity | — | Biotechnology | — |
| Dec 7, 2021 | Freenome | Series D | — | Biotechnology | — |
| Jun 25, 2021 | Kindbody | Series C | — | Employee Benefits | — |
| May 11, 2021 | Caris Life Sciences | Private Equity(PE) | — | Biotechnology | — |
| Mar 22, 2021 | Aura Biosciences | Series Unknown | — | Biotechnology | — |
| Jan 19, 2021 | Verve Therapeutics | Series B | — | Biotechnology | — |
| Aug 26, 2020 | Freenome | Series C | — | Biotechnology | — |
| Jul 8, 2020 | Kindbody | Series B | — | Employee Benefits | — |
| Mar 2, 2020 | Immunocore | Series B | — | Biotechnology | — |
| May 16, 2017 | Synlogic | Series C | — | Biotechnology | — |
| Jul 18, 2016 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| Jun 22, 2015 | Ardelyx | Post-IPO Equity | — | Biotechnology | — |
| May 12, 2015 | BeiGene | Series B | — | Biotechnology | — |
| May 7, 2015 | Adaptive Biotechnologies | Series F | — | Biotechnology | — |
| Apr 30, 2015 | Mirna Therapeutics | Series D | — | Biotechnology | — |
| Oct 13, 2014 | Invitae | Series F | — | Biotechnology | — |